Shuttle Pharmaceuticals Holdings (SHPH) Cash from Financing Activities (2021 - 2026)

Shuttle Pharmaceuticals Holdings' Cash from Financing Activities history runs 6 years deep, the most recent figure standing at $3.2 million for Q1 2026.

• On a quarterly basis, Cash from Financing Activities fell 37.31% year-over-year to $3.2 million in Q1 2026; TTM through Mar 2026 was $9.0 million, a 1.43% increase from a year earlier, with the FY2025 full-year figure at $11.0 million, up 191.66% from the prior year.
• Cash from Financing Activities rose to $3.2 million in Q1 2026 per SHPH's latest filing, from $2.3 million in the prior quarter.
• Across five years, Cash from Financing Activities topped out at $10.1 million in Q3 2022 and bottomed at -$461667.0 in Q2 2024.
• The 5-year median for Cash from Financing Activities is $525715.0 (2022), against an average of $2.1 million.
• Across the five-year window, Cash from Financing Activities slumped 396.48% in 2023 and soared 12898.47% in 2025, its largest moves.
• Year by year, Cash from Financing Activities stood at -$67363.0 in 2022, then slumped by 396.48% to -$334444.0 in 2023, then surged by 1431.66% to $4.5 million in 2024, then sank by 49.05% to $2.3 million in 2025, then jumped by 41.43% to $3.2 million in 2026.
• Per Business Quant, the three latest SHPH Cash from Financing Activities figures stand at $3.2 million (Q1 2026), $2.3 million (Q4 2025), and -$96375.0 (Q3 2025).